Danube Labs Call for Proposals - April 2022
Your research project translated into the medicines of tomorrow
CEBINA has partnered with Evotec, the industry-leading drug discovery and development company, to create Danube Labs, an initiative to accelerate academic research projects for new therapeutics to mature into projects ready for spin-out company formation, or out-licensing.
WHAT ARE WE LOOKING FOR
Innovative drug discovery projects from Universities and Research Institutes in Central and Eastern Europe
(stage of development: at least in vitro PoC, ideally in vivo PoC)
Projects with significant commercial potential and unmet medical need
Intellectual Property
(either filed patents or potential for new IP)
Collaborative team spirit
WHO WE ARE
Danube Labs is a partnership between:
We provide funding to bridge the gap between academia and industry, translating academic research projects into focused drug discovery programs
HOW IT WORKS
-
Submit a 1-3 page overview of your project to us
-
We will evaluate your project and for selected projects work with you to create a detailed acceleration project proposal
-
Project proposals will be reviewed by our Joint Steering Committee for Danube Labs awards (ca. 500k€)
-
For awarded projects research work will be carried out by you, Evotec and CEBINA to reach the planned milestones within 6 to 9 months
-
Projects that meet the defined milestones and success criteria will be commercialized either through spin-out company formation or out-licencing
Applications for this Call for Proposals are currently closed.
Please visit danubelabs.eu for updates on future calls; for any further inquiry, please contact us at info@danubelabs.eu